IRIX Q1 2026 Earnings EPS Surprises to the Upside Despite Limited Revenue Disclosure CDLX Q1 2026 Earnings Adjusted Loss Narrows EPS Surprise of 4945 Beats Expectations Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline HTH Q1 2026 Earnings Strong EPS Beat Amid Lower Stock Reaction Red River Bancshares Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline TKNO Q1 2026 Earnings Narrower Loss Beats Expectations Despite Revenue Uncertainty